EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Implementation and expansion of laboratory capacity for molecular diagnostics in response to COVID‐19 and preparedness for other emerging infectious diseases in the Islamic Emirate of Afghanistan

Murad Momin Khan, Mohamed Mostafa Tahoun, Luke W Meredith iD, Amal Barakat, Hafizullah Safi, Ahmed Nasir Hanifi, Mohammad Omar Mashal, Abdul Wahid Amiri, Alaa Abouzeid

Influenza and Other Respiratory Viruses · 2023

DOI: 10.1111/irv.13210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2023. Verfasst von Murad Momin Khan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Afghanistan Country Office World Health Organization Kabul Afghanistan. Hauptthemen laut MEDLINE: Hemorrhagic Fever, Crimean, Hemorrhagic Fever Virus, Crimean-Congo, Communicable Diseases, Emerging, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Afghanistan experienced various outbreaks before and during the Covid‐19 pandemic, including dengue, Crimean Congo hemorrhagic fever (CCHF), measles, and acute watery diarrhea (AWD). Diagnostic and surveillance support was limited, with only the Central Public Health Laboratory equipped to handle outbreak responses. This article highlights initiatives taken to improve diagnostic capabilities for COVID‐19 and other outbreaks of public health concern encountered during the pandemic.

Background

The World Health Organization (WHO) Afghanistan Country Office collaborated with the WHO Eastern Mediterranean Regional Office (EMRO), Central Public Health Laboratory (CPHL), and National Influenza Center (NIC) to enhance COVID‐19 diagnostic capacity at national and subnational facilities. To alleviate pressure on CPHL, a state‐of‐the‐art laboratory was established at the National Infectious Disease Hospital (NIDH) in Kabul in 2021–2022, while WHO EMRO facilitated the regionalization of testing to subnational facilities for dengue, CCHF, and AWD in 2022–2023.

Results

COVID‐19 testing capacity expanded nationwide to 34 Biosafety Level II labs, improving diagnosis time. Daily testing rose from 1000 in 2020 to 9200 in 2023, with 848,799 cumulative tests. NIDH identified 229 CCHF cases and 45 cases nationally. Dengue and CCHF testing, decentralized to Nangarhar and Kandahar labs, identified 338 dengue and 18 CCHF cases. AWD testing shifted to NIDH and five subnational facilities (Kandahar, Paktia, Balkh, Herat, and Nangarhar labs), while measles testing also decentralized to nine subnational facilities.

Conclusion

Afghanistan implemented a remarkable, multisectoral response to priority pathogens. The nation now possesses diagnostic expertise at national and subnational levels, supported by genomic surveillance. Future efforts should concentrate on expanding and sustaining this capacity to enhance public health responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemorrhagic Fever, CrimeanHemorrhagic Fever Virus, Crimean-CongoCommunicable Diseases, EmergingCOVID-19MeaslesDengueHumansAfghanistanCOVID-19 TestingPathology, MolecularPandemics

Stichwörter der Autor:innen

Covid‐19 pandemicdecentralized diagnosticsemerging diseasesgenomic surveillanceoutbreaks

Autor:innen und Institutionen

  • Afghanistan Country Office World Health Organization Kabul Afghanistan.
  • High Institute of Public Health Alexandria University Alexandria Egypt.
  • Eastern Mediterranean Regional Office World Health Organization Cairo Egypt.
  • Directorate of Diagnostic Services Ministry of Public Health Kabul Afghanistan.
  • Faculty of Medicine Cairo University Cairo Egypt.

ORCID-Profile: Luke W Meredith

Förderung

  • World Health Organization

Zitieren

APA

Khan, M. M., Tahoun, M. M., Meredith, L. W., Barakat, A., Safi, H., Hanifi, A. N., Mashal, M. O., Amiri, A. W., & Abouzeid, A. (2023). Implementation and expansion of laboratory capacity for molecular diagnostics in response to COVID‐19 and preparedness for other emerging infectious diseases in the Islamic Emirate of Afghanistan. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.13210

Vancouver

Khan MM, Tahoun MM, Meredith LW, Barakat A, Safi H, Hanifi AN, et al. Implementation and expansion of laboratory capacity for molecular diagnostics in response to COVID‐19 and preparedness for other emerging infectious diseases in the Islamic Emirate of Afghanistan. Influenza and Other Respiratory Viruses. 2023. doi:10.1111/irv.13210

BibTeX
@article{Khan2023,
  author = {Khan, Murad Momin and Tahoun, Mohamed Mostafa and Meredith, Luke W and Barakat, Amal and Safi, Hafizullah and Hanifi, Ahmed Nasir and Mashal, Mohammad Omar and Amiri, Abdul Wahid and Abouzeid, Alaa},
  title = {Implementation and expansion of laboratory capacity for molecular diagnostics in response to COVID‐19 and preparedness for other emerging infectious diseases in the Islamic Emirate of Afghanistan},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2023},
  doi = {10.1111/irv.13210}
}
Kostenlos starten →